Source:http://linkedlifedata.com/resource/pubmed/id/20103837
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-1-27
|
pubmed:abstractText |
The insulin-like growth factor I receptor (IGF-IR) plays a critical role in cell proliferation and survival. We previously reported that a recombinant anti-IGF-IR antibody, scFv-Fc, consisting of 1H7 monoclonal antibody (mAb)-derived single chain antibody (scFv) and human IgG1 Fc, significantly suppressed breast tumor growth, and we proposed IGFIR down-regulation as a mechanism for tumor growth inhibition (Horm Metab Res. 2003; 35:836, Cancer Res. 2003; 63:627). This study used MCF-7 breast cancer cells to investigate the effects of anti-IGF-IR mAbs with various epitope specificities on IGF-IR downregulation and signaling pathways. Despite their differing effects on IGF-IR signaling, all five mAbs used down-regulated IGF-IR. Inhibitor experiments indicated that anti-IGF-IR mAbs induced internalization of IGF-IR from clathrin coated-pits. Pretreatment of MCF-7 cells with methylamine substantially reduced the antibody-mediated IGF-IR down-regulation while MG115 did not. Ubiquitination of IGF-IR did not occur in MCF-7 cells after mAb treatment. These results suggest that anti-IGF-IR antibodies with different epitope-specificities can cause internalization of IGF-IR from clathrin-coated pits and down-regulation via a lysosome-dependent pathway in an IGF-IR activation-independent manner.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1881-7823
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
131-8
|
pubmed:meshHeading |
pubmed-meshheading:20103837-Antibodies, Monoclonal,
pubmed-meshheading:20103837-Cell Line, Tumor,
pubmed-meshheading:20103837-Coated Pits, Cell-Membrane,
pubmed-meshheading:20103837-Down-Regulation,
pubmed-meshheading:20103837-Female,
pubmed-meshheading:20103837-Humans,
pubmed-meshheading:20103837-Immunoblotting,
pubmed-meshheading:20103837-Immunoprecipitation,
pubmed-meshheading:20103837-Methylamines,
pubmed-meshheading:20103837-Microscopy, Fluorescence,
pubmed-meshheading:20103837-Receptor, IGF Type 1,
pubmed-meshheading:20103837-Signal Transduction
|
pubmed:year |
2009
|
pubmed:articleTitle |
Mechanisms of antibody-mediated insulin-like growth factor I receptor (IGF-IR) down-regulation in MCF-7 breast cancer cells.
|
pubmed:affiliation |
Department of Applied Biochemistry, Tokai University School of Engineering, Hiratsuka, Kanagawa, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|